Global Cell Based Assay & High Content Screening Market Report 2022 - The Workhorse of the Pharmaceutical Industry is Becoming a Central Player in Biotechnology
Dublin, May 20, 2022 (GLOBE NEWSWIRE) -- The "Cell Based Assay & High Content Screening Markets 2022 to 2026: Forecasts by User and Product. With Executive and Consultant Guides. including Customized Forecasting and Analysis. " report has been added to ResearchAndMarkets.com's offering.
Cell Based Assays are a mainstay of drug development and scientific research, and now, post pandemic, research activity is taking off. On top of this new technology is allowing Cell Based Assays to be used to measure any aspect of cell function.
This market just keeps on growing with no end in sight. The workhorse of the pharmaceutical industry is becoming a central player in biotechnology.
This is a complex area but this report will bring the entire management team up to speed, on both the technology and the opportunity. The technology is moving faster than the market. Genomics and Immunology are playing a role too.
Find the opportunities and the pitfalls. Understand growth expectations and the ultimate potential market size.
Key Topics Covered:
1. Market Guides
Situation Analysis
Guide for Executives and Marketing Staff
Guide for Investment Analysts and Management Consultants
2. Introduction and Market Definition
What are Cell Based Assays?
Clinical Trial Failures
Immuno-oncology Plays a Leading Role in Cell Based Assays
Infectious Disease Will Play a Larger Role
.4 Market Definition
Methodology
U.S. Medical Market and Pharmaceutical Research Spending -Perspective
3. Cell Based Assays - Guide to Technology
Cell Cultures
Cell Assays
Cell Viability Assays
Cell Proliferation Assays
Cytotoxicity Assays
Cell Senescence Assays
Apoptosis
Autophagy
Necrosis
Oxidative Stress
2D vs. 3D
Signalling Pathways, GPCR
Immune Regulation & Inhibition
Reporter Gene Technology
CBA Design & Development
Cell Based Assays - The Takeaway
4. Industry Overview
Players in a Dynamic Market
Academic Research Lab
Contract Research Organization
Genomic Instrumentation Supplier
Cell Separation and Viewing Supplier
Cell Line and Reagent Supplier
Pharmaceutical Company
Audit Body
Certification Body
5. Market Trends
Factors Driving Growth
Candidate Growth
Immuno-oncology
Genomic Blizzard
Technology Convergence
The Insurance Effect
Factors Limiting Growth
CBA Development Challenges
Instrument Integration
Protocols
Technology Development
3D Assays
Automation
Software
Primary Cells
Signaling and Reporter Genes
The Next Five Years
6. Cell Based Assays Recent Developments
Nanolive closes a USD 20 million Funding Round
Depixus Seeks to Commercialize 'Magnetic Tweezers' for Drug Discovery
BioAuxilium Research Expands its Cell Signaling Assay Portfolio
Droplet Genomics Debuts New Microfluidic Screening Platform
DLP Plus Single-Cell Sequencing Method Spreads From Canada to Cancer Labs Worldwide
Secondcell Bio to Make Creation of Cell Lines Easy
Nanolitre-scale cell assays developed with droplet microarray mass spec
Thermo Fisher Scientific Acquires Cell Sorting Technology
Cellink to Distribute Phasefocus High-Content Cell Imaging Platform
Axxam and FUJIFILM Cellular Dynamics Announce Strategic Alliance
Cancer Genetics to Acquire Organoid Startup Stemonix
Curi Bio Acquires Artificial Intelligence Firm Dana Solutions
CRISPR Screens Uncover Novel Cancer Therapy Targets
ERS Genomics Licenses CRISPR-Cas9 Patents to Axxam
New Transcriptomics Assay Facilitates Compound Screens
Carta Biosciences Betting on Gene Interaction Mapping
High-throughput Identifies cancer drug candidates
Velabs Therapeutics partners with Alytas Therapeutics to develop a novel immune-based therapy for obesity
InSphero platform selected to test Cyclerion's sGC stimulator technology
OcellO to provide in vitro research services to Merus
Charles River Laboratories to acquire Citoxlab
Reaction Biology Corporation Purchases ProQinase GmbH
7. Profiles of Key Cell Based Assay Companies
Abcam
Agilent
Aurora Instruments Ltd.
Axxam
Beckman Coulter Diagnostics
Becton, Dickinson and Company
BioIVT
Bio-Rad Laboratories, Inc.
BioTek Instruments
BioVision, Inc.
BMG Labtech
Cell Biolabs, Inc.
Cell Signaling Technology, Inc.
Charles River Laboratories
Cisbio Bioassays
Corning, Inc.
Cytovale
Enzo Life Sciences, Inc.
Eurofins DiscoverX Corporation
Evotec AG
Excellerate Bioscience
Fujifilm Cellular Dynamics International
Genedata
Hemogenix
Horizon Discovery
Invivogen
Leica Biosystems
Lonza Group Ltd.
Luminex Corp
Merck & Co., Inc
Miltenyi Biotec
Molecular Devices
Nanion
Ncardia
New England Biolabs, Inc.
Olympus
Origene Technologies
Perkin Elmer
Promega
Qiagen Gmbh
Reaction Biology
Recursion Pharma
Roche Diagnostics
Sartorius
Sartorius-ForteBio
Sartorius-IntelliCyt
Sony Biotechnology
SPT Labtech
Stemcells Technologies Canada Inc.
Tecan
Thermo Fisher Scientific Inc.
Vitro Biopharma
8. Global Market Size
Global Market Overview by Country
Global Market by User - Overview
Global Market by Product Class - Overview
9. Global Market by User Type
Pharma
Research
Industry/Cosmetic
10. Cell Based Assay by Product Class
Instrument
Reagent
Services
Software
11. Appendices
FDA Cancer Drug Approvals by Year
Clinical Trials Started 2010 to 2016
Share of Pharma R&D by Country
For more information about this report visit https://www.researchandmarkets.com/r/54qo87
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900